News

Filter

Current filters:

FabrazymeCerezyme

1 to 9 of 36 results

Shire says Fabry and Gaucher disease studies continue to support patient switches to Replagal and Vpriv

01-09-2011

Ireland-headquartered specialty drug firm Shire (LSE: SHP) reported positive data from several studies…

CerezymeFabrazymeGenzymePharmaceuticalRare diseasesReplagalResearchSanofiShireVpriv

Genzyme’s 2nd-qtr 2010 profits plunge on continuing Cerezyme and Fabrazyme supply problems

22-07-2010

Troubled US biotechnology firm Genzyme yesterday revealed that net profit for the second quarter of 2010…

BiotechnologyCerezymeFabrazymeFinancialGenzymePharmaceutical

US FDA to take enforcement action regarding Genzyme’s Allston plant, including financial penalties

25-03-2010

In another setback for the troubled biotechnology firm, the US Food and Drug Administration has notified…

BiotechnologyCerezymeFabrazymeFinancialGenzymeMyozymeNorth AmericaPharmaceuticalRare diseasesRegulationThyrogen

1 to 9 of 36 results

Back to top